Lirio
  • Platform
    • Platform Overview
    • Our Approach
  • Solutions
    • Solutions Overview
    • Health Systems
    • Payers
  • About
    • About Us
    • Careers
  • Resources
    • Blog & News
    • Webinars & Events
    • Digital Health Insights
    • Academic Research
  • Contact
Select Page

Lirio Research: A Novel Policy Comparison Metric for Reinforcement Learning

Christopher Symons, Ph.D. | Sep 3, 2021 | Artificial Intelligence, Behavioral Science, Blog

Reinforcement Learning

Welcome to Geek’s Corner! Lirio believes strongly in advancing the science of behavior change AI, and that includes sharing a collection of Lirio blog posts that are a bit more technical in nature. Want to know more? Contact Lirio’s Chief Evangelist, Patrick Hunt, who can put you in contact with one of our subject matter experts.

Behavior change can be appropriately cast as a real-world reinforcement learning problem. The challenges involved in solving this problem effectively in the healthcare setting go well beyond the fact that existing tools are inadequate. Even the latest machine learning research has not addressed the full problem or incorporated many of the critical confounding factors that exist in this real-world setting. The AI team at Lirio focuses on advancing the state of the art in real-world reinforcement learning to cope with some of these challenges. For example, we developed the Adaptive Stochastic Gradient-Free (ASGF) optimization strategy to address many of the challenges present in solving real-world reinforcement learning (RL) optimization tasks.

This blog post discusses another advancement, Limited Data Estimator, which compares different approaches to applying reinforcement learning in challenging data environments.

A New Approach

Lirio’s Behavioral Reinforcement Learning Lab (BReLL) recently published a paper describing a new approach for comparing reinforcement learning policies using limited historical data. The paper explains why existing methods for comparing policies are not effective when the amount of data is extremely sparse, as is typically the case in applications of our behavior change AI platform.

The paper presents a new measure called the Limited Data Estimator (LDE) which shows “that with high confidence the LDE correctly compares target policies even when only a small number of agent-environment interactions are available,” and demonstrates its effectiveness compared to existing policy comparison methods on several learning tasks.

Why Does This Matter?

Healthcare outcomes are inordinately affected by people’s often irrational behaviors. Lirio works to promote healthy, medically recommended behaviors, but executing behavior change AI is difficult for several reasons. We need to advance the state of reinforcement learning so we can apply it more effectively in real-world scenarios, including healthcare settings that encourage patients to adopt healthy behaviors.

Dramatic Improvement Needed Offline

Unlike image and object recognition, video games, robotics, and other types of machine learning, there are still opportunities for dramatic improvement in representation and optimization in newer subfields like real-world behavioral reinforcement learning. In addition, human health behaviors are not very well understood, so much so that any kind of simulated data cannot guarantee the accuracy required for training a model.

Navigating Balancing in Healthcare

When a system interacts with people in a health-related setting, several unique challenges arise. Practical considerations can limit the number of interactions, and ethical considerations can limit exploration. When it comes to the latter issue, consider that a common challenge related to the exploration-exploitation trade-off in reinforcement learning is the issue of balancing.

Balancing refers to providing the best-known intervention guiding health outcomes compared to the risk of providing sub-optimal interventions while continuing to explore more optimal interventions that the system simply hasn’t discovered yet. The ethical questions surrounding such choices have not played a role in earlier reinforcement learning applications, yet they are core issues when interacting with patients about their health-related behaviors.

An Evolving Opportunity

The Behavioral Reinforcement Learning Lab (BReLL) at Lirio is committed to using AI to scale behavioral interventions to positively impact people’s lives. We will continue to innovate not just on our unique and proprietary solutions, but on methods that advance the efficacy and scope of real-world applications of machine learning.

 

Learn More from Lirio

To discover more about Lirio’s approach to behavior change AI and real-world lessons learned, join us for our next webinar: “The AI You Don’t Have: Scaling Personalized Behavioral Interventions,” Thursday, September 9 at 1:00 p.m. ET.

Following the interest and engagement from the in-booth session at HIMSS21, this webinar will allow for more exploration and discussion on Lirio’s behavior change AI platform and our novel applications in improving equity and access to care.

 

Register Now

 


Follow Lirio on Facebook: Facebook.com/lirio.llc, LinkedIn: LinkedIn.com/company/lirio, and Twitter: @Lirio_LLC.

Other readers viewed:

What we learned about the Future of Healthcare at HIMSS21

Lirio Launches Hyper-Personalized Vaccination Journey to Encourage Vaccine Adoption

Lirio Research: Introducing a New Form of Machine Learning Optimization

How Behavior Change AI Addresses SDOH

Share

Recent Posts

  • In the news: How Payers Can Realize Hard ROI From Hyperpersonalization
  • In the news: The importance of prevention and primary care models and how AI can elevate them
  • From suboptimal outreach to member trust barriers, new market research shows health plans’ greatest challenges
  • 5 plans of attack: How payers can succeed facing new CMS rules in 2025 – and beyond
  • The new nasal flu mist vaccine ushers in a new era of at-home healthcare

Categories

  • Artificial Intelligence
  • Behavioral Science
  • Blog
  • Briefs
  • Closing Gaps in Care
  • Condition Management
  • Consumer Acquisition & Engagement
  • Consumer Satisfaction & Loyalty
  • Digital Health
  • Health Equity
  • News
  • Uncategorized
Lirio

Knoxville: 320 Corporate Drive, NW | Knoxville, TN 37923
Franklin: 5000 Meridian Blvd, STE 200 | Franklin, TN 37067
Local: 865.243.8000 | Toll Free: 877.819.2188

Lirio on Facebook Lirio on Twitter Lirio on Linkedin
HITRUST CSF Certified
  • Terms & Conditions
  • Privacy Policy
  • Careers
©2023-2024 Lirio, Inc. All rights reserved.